Peptides Vietnam LogoPeptides Vietnam
EN/VI
Molecule MechanicsNov 2026

Wegovy Ingredients: What Is Actually Inside the Pen

Wegovy ingredients come down to one medicine, semaglutide, plus a short list of inactive helpers. That helper list changes with the form. The one-use pens hold phosphate, salt and water, the FlexTouch pen swaps the salt for phenol and propylene glycol, and the tablet carries SNAC and magnesium stearate.

The lists come from the US label, revised June 2026, which we re-read on 20 November 2026. The jobs each helper does come from European regulator reviews and two lab studies, and we say which source backs each one. For what the medicine does once it is in the body, read what is Wegovy.

On this page

Wegovy ingredients in three recipes

Every form has the same medicine. What differs is the inactive part, the helpers that hold, protect or deliver it. Here they are side by side, with the job each one does and where that job is written down.

Inactive ingredients from the US Wegovy label, section 11 and the Medication Guide (June 2026). Roles from the sources named in each cell.
FormActiveInactive ingredientsWhat the helpers do
One-use pens and prefilled shotsSemaglutideDisodium phosphate dihydrate, sodium chloride, water; hydrochloric acid or sodium hydroxide may be addedPhosphate buffers, salt sets tonicity, acid or base fine tunes pH, water is the solvent (EMA, Wegovy pen)
FlexTouch pen (one person, used more than once)SemaglutideDisodium phosphate dihydrate, phenol, propylene glycol, water; acid or base may be added. No sodium chloride listedPropylene glycol sets tonicity and phenol preserves (EMA, sister semaglutide pen with the same helpers)
Tablet (the Wegovy pill)SemaglutideSalcaprozate sodium (SNAC), magnesium stearateSNAC helps absorption in the stomach (label); magnesium stearate is a common tablet lubricant (lab study, not the label)
Wegovy basics from the US label and Drugs@FDA, checked November 2026.
PointDetail
Active ingredientSemaglutide, in every form
How it is madeYeast builds the amino acid backbone, then chemists attach a fatty side chain
FormulaC187H291N45O59
Forms on the US labelOne-use pens and prefilled shots, the FlexTouch pen, and tablets
Shortest helper listThe tablet: two inactive ingredients

Sources: Wegovy prescribing information, DailyMed (revised June 2026); EMA assessment report, Wegovy (EMA/112307/2022); EMA assessment report, Ozempic; Buckley 2018, how SNAC works (PMID 30429357); de Backere 2023, tablet lubricant study (PMID 36586635)

What is the active ingredient in Wegovy?

Semaglutide, a lab-made version of human GLP-1 that shares 94% of its sequence. It is a chain of amino acids. Yeast builds that chain by fermentation, and chemical steps finish it. The European review names the yeast as Saccharomyces cerevisiae.

Three spots differ from the body's own hormone. A swap at position 8 shields it from DPP-4, an enzyme that would cut it. A swap at position 34 leaves only one place for a fatty chain to attach. At position 26, a spacer plus a long fatty acid hangs off the chain. The European review spells that side chain out as two small spacers, a glutamic acid link and an 18 carbon fatty diacid.

That fatty tail grips albumin, a large protein in the blood. More than 99% of semaglutide in blood plasma rides on albumin, and the label calls this binding the main reason it lasts. In the end the body clears it by cutting the amino acid chain and breaking the fatty tail down step by step.

Sources: Wegovy prescribing information, DailyMed (revised June 2026); EMA assessment report, Wegovy (EMA/112307/2022); Lau 2015, semaglutide design paper (PMID 26308095)

What is in the one-use Wegovy pens?

A clear, colorless, sterile liquid made with water. Besides semaglutide and water, the label lists disodium phosphate dihydrate and sodium chloride, the chemical name for salt. The liquid sits near pH 7.4, and hydrochloric acid or sodium hydroxide may be added to fine tune it.

The US label lists these helpers without saying what each does. The European review of the Wegovy pen fills that in. The phosphate is a buffering agent that holds the pH steady, and the salt is a tonicity agent. In plain words, tonicity is how concentrated the liquid is; a review of injection pain says injectables are ideally made to match the body's own concentration. The acid and base adjust pH, and water is the solvent.

Sources: Wegovy prescribing information, DailyMed (revised June 2026); EMA assessment report, Wegovy (EMA/112307/2022); Usach 2019, injection site pain review (PMID 31587143)

How is the FlexTouch pen different?

The FlexTouch pen is made for one person and used more than once, and its recipe changes. Section 11 of the label lists disodium phosphate dihydrate, phenol, propylene glycol and water. Sodium chloride is not on that list. The label records the change but does not explain it.

Another semaglutide pen, Ozempic, uses the same helper set, and there the European regulator calls propylene glycol the tonicity agent and phenol the preservative. Its Wegovy review also refers to phenol as a preservative. So the reusable pen carries a preservative that the one-use pens do not list. Since June 2026 the label also warns that a FlexTouch pen must never be shared between patients, even if the needle is changed.

Sources: Wegovy prescribing information, DailyMed (revised June 2026); EMA assessment report, Ozempic; EMA assessment report, Wegovy (EMA/112307/2022)

What is SNAC, and why does the tablet need it?

The tablet has the shortest list and the hardest job. Its two helpers are magnesium stearate and salcaprozate sodium, better known as SNAC. Magnesium stearate is a common tablet lubricant. In one lab study of six lubricants, it lowered the force needed to push pressed tablets out of the machine. The label does not state its role in this tablet.

SNAC does the heavy lifting. The label says it helps semaglutide get absorbed, and that absorption happens mainly in the stomach. Human and dog studies found the medicine was absorbed near the tablet surface, and only when SNAC was in the tablet. In those studies, SNAC seemed to buffer acid right around the tablet, which shielded semaglutide from stomach enzymes. Those studies were run by the drug maker's own scientists.

Even with SNAC, the label puts the share of tablet semaglutide that reaches the blood at about 1% to 2%. From the shot it is about 89%. That gap is why the tablet is the hard case.

In January 2020 the European regulator reviewed an earlier semaglutide tablet. It called SNAC the main helper and a novel excipient, and said the maker sent extensive details on it. That earlier EU tablet also listed microcrystalline cellulose and povidone, so the US Wegovy tablet list is shorter. More on that older tablet is on our oral semaglutide page.

Sources: Wegovy prescribing information, DailyMed (revised June 2026); de Backere 2023, tablet lubricant study (PMID 36586635); Buckley 2018, how SNAC works (PMID 30429357); EMA assessment report, Rybelsus tablets (January 2020)

Does the label flag any Wegovy ingredient?

One helper gets its own note, for the tablets. The label says SNAC or its breakdown products show up in breast milk, and it advises against breastfeeding during treatment with the tablets. The label also says Wegovy is not for people with a known allergy (hypersensitivity) to semaglutide or to any of its inactive ingredients; its full section 4 words this as a prior serious hypersensitivity reaction.

The boxed warning is about semaglutide itself, not a helper: it caused thyroid C-cell tumors in rodents, and whether it does in humans is unknown. The full list of reported reactions is on our Wegovy side effects page.

Status, checked November 2026: the shot gained FDA approval on 4 June 2021 and the tablets on 22 December 2025. One shared label for both took effect on 18 June 2026. Both forms share two approved uses, each paired with a lower calorie diet and more activity. One is long term weight loss for adults living with obesity, or with overweight and a related health problem. The other is lowering the odds of a major heart event for adults whose heart disease comes with obesity or overweight. The shot also covers children 12 and up with obesity. It has an accelerated approval for noncirrhotic MASH, a liver disease, in adults with moderate to advanced liver scarring.

Sources: Wegovy prescribing information, DailyMed (revised June 2026); Wegovy label file, version 19, DailyMed; Wegovy approvals, Drugs@FDA via openFDA

What else do people ask about Wegovy ingredients?

What is the active ingredient in Wegovy?+

Semaglutide, and nothing else. The label names it as the only active ingredient in both the shot and the pill. It is a lab-made version of the hormone GLP-1 with three spots changed.

Does Wegovy contain salt?+

The one-use pens and prefilled shots list sodium chloride, which is table salt by its chemical name. The FlexTouch pen list does not include it, and neither does the tablet.

Does Wegovy have a preservative?+

The FlexTouch pen lists phenol, and the European regulator calls phenol a preservative in its Wegovy review. The one-use pens do not list phenol.

What is SNAC in the Wegovy pill?+

Salcaprozate sodium. The label says it helps semaglutide get absorbed, mainly in the stomach. In 2020 the European regulator called it the main helper in an earlier semaglutide tablet, and a new one at that time.

Is Wegovy made from yeast?+

Its backbone is. The label says the amino acid chain is made by yeast fermentation, and the European review names the yeast as Saccharomyces cerevisiae. The fatty side chain is then added by chemical changes.

Can someone be allergic to the inactive ingredients?+

The label lists a known allergy (hypersensitivity) to semaglutide or to any inactive ingredient in the shot or the tablet as a reason not to use Wegovy. Its section 4 describes this as a prior serious hypersensitivity reaction. It does not name a single helper as a common cause.

Do Wegovy and Ozempic have the same ingredients?+

Both contain semaglutide. The European review of Ozempic lists the same helper set that the US label lists for the Wegovy FlexTouch pen. How the two brands differ is covered on our Wegovy and Ozempic comparison page.

For the brand question in full, see is Wegovy the same as Ozempic.

Sources: Wegovy prescribing information, DailyMed (revised June 2026); EMA assessment report, Wegovy (EMA/112307/2022); EMA assessment report, Ozempic; EMA assessment report, Rybelsus tablets (January 2020)

What is inside Wegovy, in short?

The takeaway: one yeast-built medicine with a fatty tail that rides on albumin, wrapped in three different helper recipes. Phosphate, salt and water fill the one-use pens. Phenol and propylene glycol replace the salt in the FlexTouch pen. SNAC and magnesium stearate make up the tablet.

This page follows the June 2026 US label, Drugs@FDA, three European assessment reports and four papers, all read in November 2026. Ingredient amounts are left out on purpose.

Label pages are read again on the schedule in our medical review policy, and the corrections policy page says how to report a mistake.

Sources: Wegovy prescribing information, DailyMed (revised June 2026); EMA assessment report, Wegovy (EMA/112307/2022)

This page explains what the Wegovy label lists and gives no advice. It does not suggest taking, stopping or changing any medicine. Ask a licensed clinician about any health question.

Sources

  1. 1.Wegovy prescribing information and Medication Guide, Novo Nordisk, on DailyMed, revised June 2026 (read 20 November 2026): active ingredient semaglutide; peptide backbone made by yeast fermentation; changes at positions 8, 26 and 34; molecular formula C187H291N45O59; 94% sequence homology to human GLP-1; albumin binding the main reason it lasts, with more than 99% bound in plasma; cleared by cutting the backbone and beta-oxidation of the fatty side chain; the shot is a sterile, clear, colorless water-based solution near pH 7.4; inactive ingredients for the one-use pens, the FlexTouch pen and the tablets; SNAC helps absorption, mainly in the stomach; bioavailability about 1% to 2% for the tablet and 89% for the shot; the SNAC breast milk note; the excipient allergy contraindication; the boxed warning; approved uses.
  2. 2.DailyMed label file for Wegovy, read 20 November 2026: version 19, effective 18 June 2026, one document for the Wegovy shot and tablets.
  3. 3.Drugs@FDA records via openFDA, read November 2026: the shot application (NDA 215256) was approved on 4 June 2021, and the tablet application (NDA 218316) on 22 December 2025 as a new form; latest supplements for both dated 18 June 2026.
  4. 4.European Medicines Agency, Wegovy public assessment report, EMA/112307/2022: semaglutide made with recombinant DNA in yeast (Saccharomyces cerevisiae) plus chemical changes; the side chain is two ADO spacers, a gamma glutamic acid spacer and a fatty diacid; in test tube studies albumin was the main plasma protein carrying it; in the EU one-use pen, phosphate is the buffer, sodium chloride the tonicity agent, acid and base adjust pH, and water is the solvent; refers to phenol as a preservative.
  5. 5.European Medicines Agency, Ozempic public assessment report: in the semaglutide pen recipe with the same helper set as Wegovy FlexTouch, propylene glycol is the tonicity agent and phenol the preservative.
  6. 6.European Medicines Agency, Rybelsus public assessment report, 30 January 2020: salcaprozate sodium is the main excipient, a novel excipient with extensive information in the dossier; that original tablet also listed microcrystalline cellulose and povidone K90 alongside magnesium stearate.
  7. 7.Lau and colleagues, Journal of Medicinal Chemistry 2015, PMID 26308095: semaglutide has two amino acid swaps from human GLP-1 (Aib at 8, Arg at 34) and an attachment at lysine 26. Authors from Novo Nordisk.
  8. 8.Buckley and colleagues, Science Translational Medicine 2018, PMID 30429357: in human and dog studies, oral semaglutide was absorbed in the stomach, close to the tablet, and only with SNAC; SNAC buffered acid near the tablet, protecting it from enzymes. Authors from Novo Nordisk.
  9. 9.Usach and colleagues, Advances in Therapy 2019, PMID 31587143: injectable products are ideally made as isotonic solutions, close to the concentration of body fluids, to limit injection pain. General formulation science, not specific to Wegovy.
  10. 10.de Backere and colleagues, International Journal of Pharmaceutics 2023, PMID 36586635: six tablet lubricants, magnesium stearate among them, all lowered the force needed to push pressed tablets out.